STE · 8-K · 20260805PR053412

Operating Expense Trends

STERIS plc · 2026-08-05 · Importance 42 · Surprise 14

Selling, general, and administrative expense increased to $369.7 million from $353.8 million, an increase of $15.9 million or 4.5%. Research and development expense increased to $28.6 million from $26.4 million, an increase of $2.2 million or 8.3%. Total operating expenses increased to $398.3 million from $382.0 million, while fiscal 2026 included $1.8 million of restructuring expense and fiscal 2027 included no current-quarter restructuring expense. Income from operations increased to $285.8 million from $246.0 million, lifting operating margin to approximately 19.1% from 17.7%.

Key facts

• Three months ended June 30, 2026 amortization of acquired intangible assets was $65.3 million compared with $67.1 million in 2025. source
• Selling, general, and administrative expense for the quarter was $369.7 million compared with $353.8 million in the prior-year quarter. source
• Research and development expense for the quarter was $28.6 million compared with $26.4 million in the prior-year quarter. source